Allied Healthcare Products Inc. (AHPI) |
|
2.11 0.21 (11.05%)
|
01-23 16:00 |
|
Open: |
1.93 |
Pre. Close: |
1.9 |
|
High:
|
2.11 |
Low:
|
1.93 |
|
Volume:
|
493 |
Market Cap:
|
8M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.113 - 2.121 |
2.121 - 2.129 |
|
Low:
|
1.91 - 1.919 |
1.919 - 1.928 |
|
Close:
|
2.094 - 2.109 |
2.109 - 2.124 |
|
|
|
Technical analysis |
as of: 2019-01-23 4:24:39 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 2.53 One year: 2.96 |
| Support: |
Support1: 1.83 Support2: 1.62 |
| Resistance: |
Resistance1: 2.17 Resistance2: 2.53 |
| Pivot: |
1.90 |
| Moving Average: |
MA(5): 1.98 MA(20): 1.87
MA(100): 2.06  MA(250): 2.38 |
| MACD: |
MACD(12,26): 0.02 Signal(9): -0.01 |
| Stochastic oscillator: |
%K(14,3): 66.90 %D(3): 59.17 |
| RSI: |
RSI(14): 59.08 |
| 52-week: |
High: 5.25 Low: 1.62 Change(%): |
| Average Vol(K): |
3-Month: 1017 10-Days: 702 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.AHPI has closed above the upper band by 0.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 56.1% wider than normal. The large width of the bands suggest high volatility as compared to AHPI's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2017-11-27T11:02:28-05:00
Allied Healthcare Products up 22%
2017-11-24T12:17:17-05:00
Midday Gainers / Losers
2017-09-22T11:52:37-04:00
Your Daily Pharma Scoop: VanEck Vectors Biotech ETF, Esperion's Growth Potential, Pfizer's EU Approval
2017-09-21T11:36:29-04:00
Your Daily Pharma Scoop: Intercept's Buy Opportunity, Alcobra's Downfall, Shire's Japanese Approval
2017-09-20T11:31:29-04:00
Your Daily Pharma Scoop: Geron's Growth Potential, Ipsen's Xarmelo Approval, GSK's Ellipta Approved
2017-09-19T17:17:26-04:00
Your Daily Pharma Scoop: Nabriva's Further Potential, Allergan's IP Gimmick, Supernus's Positive Data
2016-09-19T14:11:34-04:00
The Micro-Cap Digest: A Net-Net Approach
2016-04-04T13:04:00-04:00
New York Appellate Court Rules Against Allied Healthcare Products in Stuyvesant Falls Power Covenant Lawsuit
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
